Ducommun Incorporated (NYSE:DCO) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 249,400 shares, an increase of 9.5% from the January 15th total of 227,700 shares. Approximately 2.3% of the company’s stock are sold short. Based on an average daily volume of 104,500 shares, the days-to-cover ratio is currently 2.4 days.
NYSE DCO traded down $0.19 on Friday, hitting $41.19. 1,127 shares of the stock were exchanged, compared to its average volume of 121,737. The company has a debt-to-equity ratio of 0.84, a current ratio of 2.35 and a quick ratio of 1.52. The business’s fifty day moving average is $43.20 and its 200 day moving average is $44.20. Ducommun has a 52 week low of $38.39 and a 52 week high of $53.41. The company has a market capitalization of $466.81 million, a PE ratio of 19.96 and a beta of 0.82.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. C M Bidwell & Associates Ltd. bought a new position in Ducommun during the 4th quarter worth approximately $32,000. Great West Life Assurance Co. Can purchased a new position in Ducommun during the 4th quarter worth $36,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Ducommun by 72.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,365 shares of the aerospace company’s stock worth $58,000 after acquiring an additional 574 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in Ducommun by 539.8% during the 3rd quarter. Tower Research Capital LLC TRC now owns 2,073 shares of the aerospace company’s stock worth $88,000 after acquiring an additional 1,749 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new position in Ducommun during the 4th quarter worth $96,000. 82.96% of the stock is currently owned by hedge funds and other institutional investors.
DCO has been the topic of a number of research reports. ValuEngine raised shares of Ducommun from a “sell” rating to a “hold” rating in a research report on Tuesday, February 4th. Zacks Investment Research lowered shares of Ducommun from a “hold” rating to a “strong sell” rating in a research report on Monday, January 6th. B. Riley reissued a “neutral” rating and issued a $55.00 price objective (down previously from $62.50) on shares of Ducommun in a research report on Thursday, January 2nd. Finally, Canaccord Genuity cut their price objective on shares of Ducommun from $54.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $48.00.
Ducommun Incorporated provides engineering and manufacturing products and services primarily to the aerospace, defense, industrial, natural resources, medical, and other industries in the United States. The company operates through two segments, Electronic Systems and Structural Systems. The Electronic Systems segment offers cable assemblies and interconnect systems; printed circuit board assemblies; high-level electronic, electromechanical, and mechanical components and assemblies, as well as lightning diversion systems; and radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, wire harnesses, surge suppressors, conformal shields, and other assemblies.
Receive News & Ratings for Ducommun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun and related companies with MarketBeat.com's FREE daily email newsletter.